PROCEPT BioRobotics Corporation announced on April 18, Mr. Colby Wood notified the board of directors (the board) of the company that he intends to resign as a member of the board and as a member of the audit committee of the board, effective at the conclusion of the board meeting on April 18, 2024. Mr. Wood?s decision to resign from the Board was not the result of any disagreement with the company, the Board, management, or any matter relating to the company?s operations, policies or practices. On April 18, 2024, the Board appointed Mr. Larry Wood as a new member of the Board and as a member of the Audit Committee of the Board, with such appointment effective April 18, 2024.

Mr. Larry Wood fills the vacancy created by the resignation of Mr. Colby Wood and his term of office as a Class I director will expire at the company?s 2025 annual meeting of stockholders and until his successor has been elected and qualified or his earlier death, resignation or removal. Mr. Larry Wood has served since February 2007, as Corporate Vice President, Transcatheter Heart Valves, and since 2023, as Group President for Surgical Structural Heart, at Edwards Lifesciences. He has more than 35 years of experience in the medical technology industry at both Edwards Lifesciences and Baxter Healthcare Corporation in positions including manufacturing management, regulatory affairs and strategic and clinical marketing, primarily for the surgical heart valve therapy business.

He received his M.B.A. from Pepperdine Graziadio Business School.